Literature DB >> 1332633

Dietary intake and nutritional status in patients with systemic sclerosis.

A C Lundberg1, A Akesson, B Akesson.   

Abstract

Oesophageal dysmotility and abnormalities of intestinal function are important manifestations in systemic sclerosis and may have a significant effect on nutrient absorption and nutritional status. In this study 30 patients with systemic sclerosis with symptoms from the gastrointestinal tract were compared with matched healthy control subjects with respect to nutrient intake (four day record), anthropometric measurements, and biochemical nutritional status. The intake of energy (8.1 and 8.4 MJ/day) and its distribution among nutrients did not differ between patients and control subjects, but the lower intake of dietary fibre among patients with systemic sclerosis suggests that they avoided food with a coarse structure, such as coarse bread. The intake of vegetables and fruit also tended to be lower among patients with systemic sclerosis. Half of the patients had a subnormal arm muscle circumference, and two patients also had a subnormal triceps skinfold thickness, indicating severe malnutrition. The concentration of ascorbic acid, alpha-tocopherol, carotene, selenium, and also the proportion of linoleic acid (18:2) in serum phosphatidylcholine was lower in patients than in control subjects.

Entities:  

Mesh:

Year:  1992        PMID: 1332633      PMCID: PMC1012420          DOI: 10.1136/ard.51.10.1143

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN: 0003-4967            Impact factor:   19.103


  28 in total

1.  Home central venous hyperalimentation in fifteen patients with severe scleroderma bowel disease.

Authors:  S C Ng; P J Clements; W E Berquist; D E Furst; H E Paulus
Journal:  Arthritis Rheum       Date:  1989-02

2.  Organ manifestations in 100 patients with progressive systemic sclerosis: a comparison between the CREST syndrome and diffuse scleroderma.

Authors:  A Akesson; F A Wollheim
Journal:  Br J Rheumatol       Date:  1989-08

3.  Bile acid malabsorption in progressive systemic sclerosis.

Authors:  P Pazzi; S Putinati; B Bagni; M Govoni; F Trotta
Journal:  Gut       Date:  1988-04       Impact factor: 23.059

4.  Arm anthropometry in a large reference population and in surgical patients.

Authors:  T Symreng
Journal:  Clin Nutr       Date:  1982-12       Impact factor: 7.324

5.  Nutrient intake and biochemical markers of nutritional status during long-term follow-up after total and partial gastrectomy.

Authors:  C Staël von Holstein; E Ibrahimbegovic; B Walther; B Akesson
Journal:  Eur J Clin Nutr       Date:  1992-04       Impact factor: 4.016

6.  Lipolysis of polyenoic fatty acid esters of human chylomicrons by lipoprotein lipase.

Authors:  B Ekström; A Nilsson; B Akesson
Journal:  Eur J Clin Invest       Date:  1989-06       Impact factor: 4.686

7.  Advanced scleroderma bowel: complications and management.

Authors:  F J Stafford-Brady; H J Kahn; T M Ross; M L Russell
Journal:  J Rheumatol       Date:  1988       Impact factor: 4.666

8.  Vitamin D metabolites in generalized scleroderma. Evidence of a normal cutaneous and intestinal supply with vitamin D.

Authors:  J Serup; H Hagdrup
Journal:  Acta Derm Venereol       Date:  1985       Impact factor: 4.437

Review 9.  Swallowing disorders.

Authors:  A Merlo; S Cohen
Journal:  Annu Rev Med       Date:  1988       Impact factor: 13.739

10.  Nutritional support in patients with systemic scleroderma.

Authors:  G Grabowski; J P Grant
Journal:  JPEN J Parenter Enteral Nutr       Date:  1989 Mar-Apr       Impact factor: 4.016

View more
  17 in total

1.  The oxidant-antioxidant balance in systemic sclerosis cases with interstitial lung involvement.

Authors:  Benan Musellim; Hande Ikitimur; Hafize Uzun; Gul Ongen
Journal:  Rheumatol Int       Date:  2006-09-02       Impact factor: 2.631

2.  Management of gastrointestinal involvement in scleroderma.

Authors:  Vivek Nagaraja; Zsuzsanna H McMahan; Terri Getzug; Dinesh Khanna
Journal:  Curr Treatm Opt Rheumatol       Date:  2015-03-01

Review 3.  Evolutionary medicine and bone loss in chronic inflammatory diseases--A theory of inflammation-related osteopenia.

Authors:  Rainer H Straub; Maurizio Cutolo; Roberto Pacifici
Journal:  Semin Arthritis Rheum       Date:  2015-04-30       Impact factor: 5.532

4.  Validation of Serbian version of UCLA Scleroderma Clinical Trial Consortium Gastrointestinal Tract Instrument in 104 patients with systemic sclerosis.

Authors:  Ana Zekovic; Nemanja Damjanov
Journal:  Rheumatol Int       Date:  2017-03-07       Impact factor: 2.631

5.  Oxidative stress in Systemic Sclerosis.

Authors:  G Simonini; M M Cerinic; S Generini; M Zoppi; M Anichini; C Cesaretti; A Pignone; F Falcini; T Lotti; M Cagnoni
Journal:  Mol Cell Biochem       Date:  1999-06       Impact factor: 3.396

6.  Risk factors for body composition abnormalities in systemic sclerosis.

Authors:  Thais F Marighela; Patrícia de S Genaro; Marcelo M Pinheiro; Vera L Szejnfeld; Cristiane Kayser
Journal:  Clin Rheumatol       Date:  2013-04-03       Impact factor: 2.980

7.  Lipid peroxidation and trace elements in systemic sclerosis.

Authors:  Mohammed Tikly; Kalavati Channa; Penny Theodorou; Mairam Gulumian
Journal:  Clin Rheumatol       Date:  2005-10-25       Impact factor: 2.980

8.  Cutaneous Connective Tissue Diseases: Epidemiology, Diagnosis, and Treatment.

Authors:  Bobby Y Reddy; Basil M Hantash
Journal:  Open Dermatol J       Date:  2009-01-01

9.  Effects of micronutrient antioxidants (alpha-tocopherol and ascorbic acid) on skin thickening and lung function in patients with early diffuse systemic sclerosis.

Authors:  Predrag Ostojic; Nemanja Damjanov
Journal:  Rheumatol Int       Date:  2010-03-23       Impact factor: 2.631

10.  Iloprost infusion does not reduce oxidative stress in systemic sclerosis.

Authors:  Alessandro Volpe; Domenico Biasi; Paola Caramaschi; Lisa Maria Bambara; Antonio Carletto; Maurizio Degan; Pietro Minuz
Journal:  Rheumatol Int       Date:  2007-08-18       Impact factor: 2.631

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.